In an announcement dated October 19, 2026, Ultima Genomics said its UG200 Sequencing Platform has been selected to power a large-scale single-cell immune profiling study with IMU Biosciences and UK Biobank, covering an initial 80,000 blood samples from UK Biobank participants and producing a foundational immune dataset intended for AI research. Study Design and Participating Platforms IMU Biosciences announced the collaboration from London the same day, naming UK Biobank, Waters Corporation and…